New glycemic targets for patients with diabetes from the Japan Diabetes Society View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-11-16

AUTHORS

Eiichi Araki, Masakazu Haneda, Masato Kasuga, Takeshi Nishikawa, Tatsuya Kondo, Kohjiro Ueki, Takashi Kadowaki

ABSTRACT

In the “Evidence-based Practice Guideline for the Treatment for Diabetes in Japan 2013,” a new concept of glycemic control in patients with diabetes in Japan has been declared from the Japan Diabetes Society. The main objective value of HbA1c was set to <7% from the perspective of preventing microvascular complications. On the other hand, the objective in cases where objectives can be attained by appropriate dietary or exercise therapy or during pharmacotherapy without the occurrence of side effects such as hypoglycemia was set to <6%, and the objective in cases where intensification of treatment was considered difficult because of the side effects such as hypoglycemia or for other reasons was set to <8%. Treatment objectives should be established individually, considering the age, duration of disease, organ damage, risk of hypoglycemia, support structure, etc. More... »

PAGES

327-330

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13340-016-0297-4

DOI

http://dx.doi.org/10.1007/s13340-016-0297-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033211819

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30603281


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.274841.c", 
          "name": [
            "Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Araki", 
        "givenName": "Eiichi", 
        "id": "sg:person.01166114517.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166114517.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Asahikawa Medical University, Asahikawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.252427.4", 
          "name": [
            "Asahikawa Medical University, Asahikawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haneda", 
        "givenName": "Masakazu", 
        "id": "sg:person.01342044323.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342044323.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Center for Global Health and Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.45203.30", 
          "name": [
            "National Center for Global Health and Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kasuga", 
        "givenName": "Masato", 
        "id": "sg:person.0620475144.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620475144.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415538.e", 
          "name": [
            "Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan", 
            "National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishikawa", 
        "givenName": "Takeshi", 
        "id": "sg:person.01173064214.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173064214.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan", 
          "id": "http://www.grid.ac/institutes/grid.274841.c", 
          "name": [
            "Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondo", 
        "givenName": "Tatsuya", 
        "id": "sg:person.01124751014.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124751014.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.45203.30", 
          "name": [
            "Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueki", 
        "givenName": "Kohjiro", 
        "id": "sg:person.015700630322.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015700630322.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kadowaki", 
        "givenName": "Takashi", 
        "id": "sg:person.01353472360.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353472360.41"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00125-004-1574-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011427923", 
          "https://doi.org/10.1007/s00125-004-1574-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-11-16", 
    "datePublishedReg": "2016-11-16", 
    "description": "In the \u201cEvidence-based Practice Guideline for the Treatment for Diabetes in Japan 2013,\u201d a new concept of glycemic control in patients with diabetes in Japan has been declared from the Japan Diabetes Society. The main objective value of HbA1c was set to <7% from the perspective of preventing microvascular complications. On the other hand, the objective in cases where objectives can be attained by appropriate dietary or exercise therapy or during pharmacotherapy without the occurrence of side effects such as hypoglycemia was set to <6%, and the objective in cases where intensification of treatment was considered difficult because of the side effects such as hypoglycemia or for other reasons was set to <8%. Treatment objectives should be established individually, considering the age, duration of disease, organ damage, risk of hypoglycemia, support structure, etc.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13340-016-0297-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044715", 
        "issn": [
          "2190-1678", 
          "2190-1686"
        ], 
        "name": "Diabetology International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "Japan Diabetes Society", 
      "Diabetes Society", 
      "side effects", 
      "evidence-based practice guidelines", 
      "new glycemic targets", 
      "intensification of treatment", 
      "duration of disease", 
      "risk of hypoglycemia", 
      "microvascular complications", 
      "glycemic targets", 
      "glycemic control", 
      "organ damage", 
      "practice guidelines", 
      "hypoglycemia", 
      "diabetes", 
      "Japan 2013", 
      "treatment objectives", 
      "patients", 
      "treatment", 
      "complications", 
      "pharmacotherapy", 
      "therapy", 
      "disease", 
      "age", 
      "risk", 
      "cases", 
      "objective", 
      "duration", 
      "guidelines", 
      "effect", 
      "damage", 
      "target", 
      "control", 
      "occurrence", 
      "reasons", 
      "hand", 
      "Japan", 
      "society", 
      "values", 
      "new concept", 
      "perspective", 
      "intensification", 
      "support structure", 
      "concept", 
      "structure", 
      "objective value"
    ], 
    "name": "New glycemic targets for patients with diabetes from the Japan Diabetes Society", 
    "pagination": "327-330", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033211819"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13340-016-0297-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30603281"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13340-016-0297-4", 
      "https://app.dimensions.ai/details/publication/pub.1033211819"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_698.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13340-016-0297-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13340-016-0297-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13340-016-0297-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13340-016-0297-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13340-016-0297-4'


 

This table displays all metadata directly associated to this object as RDF triples.

168 TRIPLES      21 PREDICATES      72 URIs      63 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13340-016-0297-4 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N6245adc0459f4dd4a8d49c2208d61f29
4 schema:citation sg:pub.10.1007/s00125-004-1574-5
5 schema:datePublished 2016-11-16
6 schema:datePublishedReg 2016-11-16
7 schema:description In the “Evidence-based Practice Guideline for the Treatment for Diabetes in Japan 2013,” a new concept of glycemic control in patients with diabetes in Japan has been declared from the Japan Diabetes Society. The main objective value of HbA1c was set to <7% from the perspective of preventing microvascular complications. On the other hand, the objective in cases where objectives can be attained by appropriate dietary or exercise therapy or during pharmacotherapy without the occurrence of side effects such as hypoglycemia was set to <6%, and the objective in cases where intensification of treatment was considered difficult because of the side effects such as hypoglycemia or for other reasons was set to <8%. Treatment objectives should be established individually, considering the age, duration of disease, organ damage, risk of hypoglycemia, support structure, etc.
8 schema:genre article
9 schema:isAccessibleForFree true
10 schema:isPartOf N3a776332b8d747cfa104b5d661b595bd
11 N9323d9236a234b778bda0ed56290eed5
12 sg:journal.1044715
13 schema:keywords Diabetes Society
14 Japan
15 Japan 2013
16 Japan Diabetes Society
17 age
18 cases
19 complications
20 concept
21 control
22 damage
23 diabetes
24 disease
25 duration
26 duration of disease
27 effect
28 evidence-based practice guidelines
29 glycemic control
30 glycemic targets
31 guidelines
32 hand
33 hypoglycemia
34 intensification
35 intensification of treatment
36 microvascular complications
37 new concept
38 new glycemic targets
39 objective
40 objective value
41 occurrence
42 organ damage
43 patients
44 perspective
45 pharmacotherapy
46 practice guidelines
47 reasons
48 risk
49 risk of hypoglycemia
50 side effects
51 society
52 structure
53 support structure
54 target
55 therapy
56 treatment
57 treatment objectives
58 values
59 schema:name New glycemic targets for patients with diabetes from the Japan Diabetes Society
60 schema:pagination 327-330
61 schema:productId N21217c4b5d69469b8f7b013342a25397
62 N9b5d5b042cb74ee0ad1b88d5263a9187
63 Nadfa9c00399f4682801b7411dc00072e
64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033211819
65 https://doi.org/10.1007/s13340-016-0297-4
66 schema:sdDatePublished 2022-10-01T06:41
67 schema:sdLicense https://scigraph.springernature.com/explorer/license/
68 schema:sdPublisher Nd98c09ed42224738806da79ce9a1adeb
69 schema:url https://doi.org/10.1007/s13340-016-0297-4
70 sgo:license sg:explorer/license/
71 sgo:sdDataset articles
72 rdf:type schema:ScholarlyArticle
73 N1b62ee8bd51546ca895e3256b103dbc1 rdf:first sg:person.01342044323.24
74 rdf:rest Nac9d28fb628e4cd1be5370946ea1d153
75 N21217c4b5d69469b8f7b013342a25397 schema:name dimensions_id
76 schema:value pub.1033211819
77 rdf:type schema:PropertyValue
78 N3a776332b8d747cfa104b5d661b595bd schema:issueNumber 4
79 rdf:type schema:PublicationIssue
80 N4330c041fad64dd89c2a41536bdc36fb rdf:first sg:person.01173064214.81
81 rdf:rest Naefaf2012b8346ee85963cf3f0af68d5
82 N57e8f80fdd72475ca42577d9f36fe07b rdf:first sg:person.015700630322.33
83 rdf:rest N9d2aa12cfc774189800d12dc06feadf2
84 N6245adc0459f4dd4a8d49c2208d61f29 rdf:first sg:person.01166114517.50
85 rdf:rest N1b62ee8bd51546ca895e3256b103dbc1
86 N9323d9236a234b778bda0ed56290eed5 schema:volumeNumber 7
87 rdf:type schema:PublicationVolume
88 N9b5d5b042cb74ee0ad1b88d5263a9187 schema:name pubmed_id
89 schema:value 30603281
90 rdf:type schema:PropertyValue
91 N9d2aa12cfc774189800d12dc06feadf2 rdf:first sg:person.01353472360.41
92 rdf:rest rdf:nil
93 Nac9d28fb628e4cd1be5370946ea1d153 rdf:first sg:person.0620475144.35
94 rdf:rest N4330c041fad64dd89c2a41536bdc36fb
95 Nadfa9c00399f4682801b7411dc00072e schema:name doi
96 schema:value 10.1007/s13340-016-0297-4
97 rdf:type schema:PropertyValue
98 Naefaf2012b8346ee85963cf3f0af68d5 rdf:first sg:person.01124751014.55
99 rdf:rest N57e8f80fdd72475ca42577d9f36fe07b
100 Nd98c09ed42224738806da79ce9a1adeb schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
103 schema:name Medical and Health Sciences
104 rdf:type schema:DefinedTerm
105 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
106 schema:name Clinical Sciences
107 rdf:type schema:DefinedTerm
108 sg:journal.1044715 schema:issn 2190-1678
109 2190-1686
110 schema:name Diabetology International
111 schema:publisher Springer Nature
112 rdf:type schema:Periodical
113 sg:person.01124751014.55 schema:affiliation grid-institutes:grid.274841.c
114 schema:familyName Kondo
115 schema:givenName Tatsuya
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124751014.55
117 rdf:type schema:Person
118 sg:person.01166114517.50 schema:affiliation grid-institutes:grid.274841.c
119 schema:familyName Araki
120 schema:givenName Eiichi
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166114517.50
122 rdf:type schema:Person
123 sg:person.01173064214.81 schema:affiliation grid-institutes:grid.415538.e
124 schema:familyName Nishikawa
125 schema:givenName Takeshi
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173064214.81
127 rdf:type schema:Person
128 sg:person.01342044323.24 schema:affiliation grid-institutes:grid.252427.4
129 schema:familyName Haneda
130 schema:givenName Masakazu
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342044323.24
132 rdf:type schema:Person
133 sg:person.01353472360.41 schema:affiliation grid-institutes:grid.26999.3d
134 schema:familyName Kadowaki
135 schema:givenName Takashi
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353472360.41
137 rdf:type schema:Person
138 sg:person.015700630322.33 schema:affiliation grid-institutes:grid.45203.30
139 schema:familyName Ueki
140 schema:givenName Kohjiro
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015700630322.33
142 rdf:type schema:Person
143 sg:person.0620475144.35 schema:affiliation grid-institutes:grid.45203.30
144 schema:familyName Kasuga
145 schema:givenName Masato
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620475144.35
147 rdf:type schema:Person
148 sg:pub.10.1007/s00125-004-1574-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011427923
149 https://doi.org/10.1007/s00125-004-1574-5
150 rdf:type schema:CreativeWork
151 grid-institutes:grid.252427.4 schema:alternateName Asahikawa Medical University, Asahikawa, Japan
152 schema:name Asahikawa Medical University, Asahikawa, Japan
153 rdf:type schema:Organization
154 grid-institutes:grid.26999.3d schema:alternateName Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
155 schema:name Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
156 rdf:type schema:Organization
157 grid-institutes:grid.274841.c schema:alternateName Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan
158 schema:name Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan
159 rdf:type schema:Organization
160 grid-institutes:grid.415538.e schema:alternateName National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
161 schema:name Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan
162 National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
163 rdf:type schema:Organization
164 grid-institutes:grid.45203.30 schema:alternateName Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
165 National Center for Global Health and Medicine, Tokyo, Japan
166 schema:name Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
167 National Center for Global Health and Medicine, Tokyo, Japan
168 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...